Why some teens may need long-acting injectables

Abstract

The Food and Drug Administration (FDA) has not approved long-acting injectable (LAI) antipsychotic medications for patients under age 18, but researchers have found that for some teens, prescribing these medications off-label is helpful. This is particularly true in teens with bipolar disorder who forget or don't want to take their oral medications, according to the researchers, who found that the LAI antipsychotics were effective, and recommend more FDA trials.